TP53 and metabolic dysfunction-associated steatohepatitis: Phytochemcial analysis coupling with network pharmacology analyses identify key targets of DXR for treating MASH, including AKT1, EGFR, TP53, STAT3, and IL6, with biological processes related to oxidative stress.